www.bic.lv
Our news
BIC Securities advised Feron on acquisition of an API production business in Russia
01/04/2022

Feron, one of the leading Russian pharmaceutical companies, has acquired active pharmaceutical ingredients (API) production business.

BIC Securities acted as exclusive financial adviser to Feron.

Transaction details are not disclosed.

Return to archive
Our company
Profile
Team
Offices
Publications and presentations
Our news


Quick search



Copyright © 1999-2023 BIC Securities.
All rights reserved.